On Friday, British pharma giant GlaxoSmithKline said, it plans to set up a new life sciences campus within its R&D site in Stevenage, England, by raising up to $552.76 million (400 million pounds) by selling some land at the facility. In… Read More ›
The strategic development places the Ian Read as its chairman and opens up the CEO post which could be filled at a later date. Under Read’s steady stewardship, Pfizer Inc’s stock has gone up by 160% since December 2010. Pfizer… Read More ›
The move is aimed at sharpening it focus on its prescription drugs business. On Friday, Novartis disclosed its plans of divesting all of its assets from its Alcon eye care devices business as it sharpens its focus on prescription drugs…. Read More ›
The biggest drivers of growth are likely to be cancer drugs and those that target hypertension and mental health. As per the findings of a report released by QuintilesIMS Holding, the market for prescription drugs is set to grow in… Read More ›
manageria.biz 